Rebif will not cure MS; it will only decrease the frequency of relapse symptoms. Common side effects of Rebif include pain, swelling, or redness at the injection site. Flu-like symptoms such as headache, dizziness, fatigue, fever, chills, stomach pain, runny or stuffy nose, and muscle aches may occur when you first start Rebif.
What are the side effects of Rebif (interferon beta-1a)?
Note: This document contains side effect information about interferon beta-1a. Some of the dosage forms listed on this page may not apply to the brand name Rebif. Common side effects of Rebif include: flu-like symptoms, fever, headache, myalgia, nausea, and chills. Other side effects include: anemia.
Can Rebif cause weight gain or weight loss?
Changes in weight, such as weight gain or weight loss, haven’t been reported as common side effects of Rebif. However, weight changes may be a sign of liver damage, which is a possible side effect of Rebif. If you notice changes in your body weight while taking Rebif, talk with your doctor right away.
Can Rebif cause liver damage?
Liver effects, including liver damage, have been reported in people taking Rebif. In fact, changes in blood levels of liver enzymes are a common side effect of the drug.
Common side effects include flu-like symptoms and injection site reactions. What is Rebif used for in MS? Rebif is a disease modifying drug (DMD) for relapsing remitting MS.
What is Rebif used to treat?
Indication: Rebif ® is a prescription medicine used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Proven efficacy. Established safety profile.
How do I self-inject Rebif?
You self-inject Rebif under the skin three times a week. Rebif is supplied in several different formats – your MS nurse can explain the different injection devices and help you choose the most appropriate one for you.
What is Rebif (interferon)?
Interferons are proteins that occur naturally in the immune system. It is thought that beta interferon acts by reducing both inflammation and the immune response that is attacking the body’s own myelin. Rebif has been studied extensively since the early 1990s.
